Single session subconvulsive electrical stimulation has rapid therapeutic effects and reduces length of hospitalization in patients in an acute manic episode

• Autor(a) principal: Silva-dos-Santos, Amilcar
• Data de Publicação: 2023
• Outros Autores: Youssef, Nagy A., Bravo, Joana, Sales, Miguel, Velho, Maria Vaz, Simões, Fábio, Gaspar, Beatriz, Gracias, Maria João, Lopes, Joana, Duarte, Rita, Lara, Elsa, Gusmão, Ricardo, Sackeim, Harold A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10362/159716
• topic: Neuroscience(all); Biophysics; Clinical Neurology

Funding Information: Dr. Youssef discloses that in the last 3 years he has received support from the US National Institute of Health (NIH), Department of Veteran Affairs, Department of Defense, and the American Foundation of Suicide Prevention, as well as research support, but not salary support, from Merck & Co and the MECTA Corporation. He receives royalties from Elsevier Inc.Dr. Sackeim serves as a scientific adviser to and receives consulting fees from Cerebral Therapeutics Inc, Holmusk Inc, LivaNova PLC, MECTA Corporation, NeuroInsights Inc., Neurolief LTD, Neuronetics Inc, Parow Entheobiosciences LLC and SigmaStim LLC. He receives honoraria and royalties from Elsevier Inc and Oxford University Press. He is the inventor on non-remunerative US patents for Focal Electrically-Administered Seizure Therapy (FEAST), titration in the current domain in ECT, and the adjustment of current in ECT devices, each held by SigmaStim LLC. He is also the originator of magnetic seizure therapy (MST).